Edwards Lifesciences (EW) Target Lifted to $90 at Northland Capital Markets on TMRV Opportunity, Valuation
Tweet Send to a Friend
Northland Capital Markets analyst Suraj Kalia reiterated an Outperform rating on Edwards Lifesciences (NYSE: EW) and raised his price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE